Novel mechanisms of resistance to inhibitors of DNA topoisomerases.
Beck
W T
WT
Cancer Center (m/c 569), College of Medicine, University of Illinois at Chicago 60607-7173, USA.
Khélifa
T
T
Kusumoto
H
H
Mo
Y Y
YY
Rodgers
Q
Q
Wolverton
J S
JS
Wang
Q
Q
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D002467:Cell Nucleus / Q000201:enzymology; D004264:DNA Topoisomerases, Type I / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D016195:G2 Phase; D016758:Genes, jun / Q000235:genetics; D006801:Humans; D007938:Leukemia; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013713:Teniposide / Q000494:pharmacology*; D013858:Thiobarbiturates / Q000494:pharmacology*; D059004:Topoisomerase I Inhibitors; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D012333:RNA, Messenger; D013858:Thiobarbiturates; D059004:Topoisomerase I Inhibitors; D013713:Teniposide; D004264:DNA Topoisomerases, Type I; C045459:merbarone